ArticleMalaria journal2012
Target product profiles for protecting against outdoor malaria transmission.
Article in Malaria journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 50 citations in OpenAlex.
- Risk factors for contracting malaria in six wards of Mudzi District, Zimbabwe: A case control-study.PloS one · 2025Article
- Malaria prevention interventions beyond long-lasting insecticidal nets and indoor residual spraying in low- and middle-income countries: a scoping review.Malaria journal · 2022Article
- Evaluating putative repellent 'push' and attractive 'pull' components for manipulating the odour orientation of host-seeking malaria vectors in the peri-domestic space.Parasites & vectors · 2021Article
- Communal Innovations: Inspiring Neighborhoods of Hope and Advocacy.Journal of health communication · 2020Article
- Evaluation of personal protection afforded by repellent-treated sandals against mosquito bites in south-eastern Tanzania.Malaria journal · 2020Article
- Creating mosquito-free outdoor spaces using transfluthrin-treated chairs and ribbons.Malaria journal · 2020Article
- Electrospinning repellents in polyvinyl alcohol-nanofibres for obtaining mosquito-repelling fabrics.Royal Society open science · 2019Article
- The portfolio effect cushions mosquito populations and malaria transmission against vector control interventions.Malaria journal · 2018Article
- Field assessment of a novel spatial repellent for malaria control: a feasibility and acceptability study in Mondulkiri, Cambodia.Malaria journal · 2017Article
- Article
- A low technology emanator treated with the volatile pyrethroid transfluthrin confers long term protection against outdoor biting vectors of lymphatic filariasis, arboviruses and malaria.PLoS neglected tropical diseases · 2017Article
- Attacking the mosquito on multiple fronts: Insights from the Vector Control Optimization Model (VCOM) for malaria elimination.PloS one · 2017Article
- Developing an expanded vector control toolbox for malaria elimination.BMJ global health · 2017Article
- The risk of incomplete personal protection coverage in vector-borne disease.Journal of the Royal Society, Interface · 2016Article
- Outdoor-sleeping and other night-time activities in northern Ghana: implications for residual transmission and malaria prevention.Malaria journal · 2015Observational
- Colonization of malaria vectors under semi-field conditions as a strategy for maintaining genetic and phenotypic similarity with wild populations.Malaria journal · 2015Article
- Comparative assessment of diverse strategies for malaria vector population control based on measured rates at which mosquitoes utilize targeted resource subsets.Malaria journal · 2014Article
- Characterizing, controlling and eliminating residual malaria transmission.Malaria journal · 2014Review
- Made-to-measure malaria vector control strategies: rational design based on insecticide properties and coverage of blood resources for mosquitoes.Malaria journal · 2014Review
- Potential causes and consequences of behavioural resilience and resistance in malaria vector populations: a mathematical modelling analysis.Malaria journal · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLong-lasting insecticidal nets (LLINs) and indoor residual sprays (IRS) have decimated malaria transmission by killing indoor-feeding mosquitoes. However, complete elimination of malaria transmission with these proven methods is confounded by vectors that evade pesticide contact by feeding outdoors.
methodsFor any assumed level of indoor coverage and personal protective efficacy with insecticidal products, process-explicit malaria transmission models suggest that insecticides that repel mosquitoes will achieve less impact upon transmission than those that kill them outright. Here such models are extended to explore how outdoor use of products containing either contact toxins or spatial repellents might augment or attenuate impact of high indoor coverage of LLINs relying primarily upon contact toxicity.
resultsLLIN impact could be dramatically enhanced by high coverage with spatial repellents conferring near-complete personal protection, but only if combined indoor use of both measures can be avoided where vectors persist that prefer feeding indoors upon humans. While very high levels of coverage and efficacy will be required for spatial repellents to substantially augment the impact of LLINs or IRS, these ambitious targets may well be at least as practically achievable as the lower requirements for equivalent impact using contact insecticides.
conclusionsVapour-phase repellents may be more acceptable, practical and effective than contact insecticides for preventing outdoor malaria transmission because they need not be applied to skin or clothing and may protect multiple occupants of spaces outside of treatable structures such as nets or houses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.